| scholarly article | Q13442814 |
| P2093 | author name string | Junfeng Wang | |
| Dawei Sun | |||
| Fenghai Ren | |||
| Sainan Pang | |||
| Shidong Xu | |||
| Yanbo Wang | |||
| Benkun Liu | |||
| Shibo Zhang | |||
| Jianlong Bu | |||
| Zigeng Xu | |||
| P2860 | cites work | SOCS, inflammation, and cancer | Q26991808 |
| Global cancer statistics, 2012 | Q27860501 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer | Q28082255 | ||
| Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma | Q40399429 | ||
| Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases. | Q45080808 | ||
| Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis | Q28257114 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship | Q28278682 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status | Q30278774 | ||
| Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
| Expression of microRNAs in basal cell carcinoma. | Q34271420 | ||
| Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab. | Q34343614 | ||
| Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs | Q34738450 | ||
| MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. | Q34964080 | ||
| Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. | Q35011389 | ||
| Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy | Q35039281 | ||
| CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling. | Q35643695 | ||
| MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 | Q36355801 | ||
| Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation | Q36413232 | ||
| The BIM deletion polymorphism is a prognostic biomarker of EGFR-TKIs response in NSCLC: A systematic review and meta-analysis | Q36413266 | ||
| Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met | Q36545471 | ||
| Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development. | Q36946799 | ||
| Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer | Q37225326 | ||
| Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. | Q37392616 | ||
| MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway. | Q37423551 | ||
| The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression | Q37501595 | ||
| Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. | Q37588369 | ||
| SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer | Q38010528 | ||
| ALK inhibitors in the treatment of advanced NSCLC. | Q38127953 | ||
| MEK inhibition in non-small cell lung cancer | Q38254501 | ||
| MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer | Q38710060 | ||
| MicroRNA-455-3p Inhibits Tumor Cell Proliferation and Induces Apoptosis in HCT116 Human Colon Cancer Cells. | Q38730451 | ||
| The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer. | Q38741464 | ||
| MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6. | Q38796695 | ||
| MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1. | Q38800334 | ||
| microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells. | Q38873260 | ||
| Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. | Q39017421 | ||
| Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers | Q39078029 | ||
| P433 | issue | 70 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 114956-114965 | |
| P577 | publication date | 2017-11-20 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer | |
| P478 | volume | 8 |
| Q91867303 | Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis |
| Q90929458 | Exploring specific prognostic biomarkers in triple-negative breast cancer |
| Q90441720 | Inhibitory effect of microRNA-455-5p on biological functions of esophageal squamous cell carcinoma Eca109 cells via Rab31 |
| Q64108079 | MicroRNA in Lung Cancer Metastasis |
| Q64234036 | MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2 |
| Q61815418 | Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p |
| Q92922478 | Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma |
| Q61451706 | The Functional Mechanisms of miR-30b-5p in Acute Lung Injury in Children |
| Q58581562 | lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer |
Search more.